A detailed history of Voya Investment Management LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Voya Investment Management LLC holds 36,967 shares of UTHR stock, worth $13 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
36,967
Previous 31,037 19.11%
Holding current value
$13 Million
Previous $9.89 Million 34.0%
% of portfolio
0.02%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$311.04 - $363.55 $1.84 Million - $2.16 Million
5,930 Added 19.11%
36,967 $13.2 Million
Q2 2024

Dec 03, 2024

SELL
$228.26 - $319.04 $1.35 Million - $1.89 Million
-5,930 Reduced 16.04%
31,037 $9.89 Million
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $138,782 - $193,976
608 Added 2.0%
31,037 $9.89 Million
Q1 2024

Dec 06, 2024

SELL
$210.76 - $249.51 $1.38 Million - $1.63 Million
-6,538 Reduced 17.69%
30,429 $6.99 Million
Q1 2024

May 15, 2024

SELL
$210.76 - $249.51 $25.6 Million - $30.3 Million
-121,359 Reduced 79.95%
30,429 $6.99 Million
Q4 2023

Feb 14, 2024

SELL
$214.88 - $256.94 $294,815 - $352,521
-1,372 Reduced 0.9%
151,788 $33.4 Million
Q3 2023

Nov 14, 2023

SELL
$211.82 - $248.24 $957,002 - $1.12 Million
-4,518 Reduced 2.87%
153,160 $34.6 Million
Q2 2023

Aug 14, 2023

SELL
$205.19 - $232.99 $7.58 Million - $8.61 Million
-36,957 Reduced 18.99%
157,678 $34.8 Million
Q1 2023

May 15, 2023

BUY
$212.99 - $276.17 $1.46 Million - $1.9 Million
6,865 Added 3.66%
194,635 $43.6 Million
Q4 2022

Feb 14, 2023

SELL
$205.95 - $280.43 $6.05 Million - $8.23 Million
-29,353 Reduced 13.52%
187,770 $52.2 Million
Q3 2022

Mar 03, 2023

BUY
$203.3 - $244.17 $5.97 Million - $7.17 Million
29,353 Added 15.63%
217,123 $45.5 Million
Q3 2022

Nov 14, 2022

BUY
$203.3 - $244.17 $3.01 Million - $3.61 Million
14,795 Added 7.31%
217,123 $45.5 Million
Q2 2022

Aug 15, 2022

SELL
$174.81 - $241.14 $1.26 Million - $1.74 Million
-7,228 Reduced 3.45%
202,328 $47.7 Million
Q1 2022

May 16, 2022

SELL
$166.16 - $213.96 $934,151 - $1.2 Million
-5,622 Reduced 2.61%
209,556 $37.6 Million
Q4 2021

Feb 14, 2022

SELL
$184.32 - $216.08 $9.46 Million - $11.1 Million
-51,302 Reduced 19.25%
215,178 $46.5 Million
Q3 2021

Nov 15, 2021

SELL
$179.86 - $214.88 $5.91 Million - $7.06 Million
-32,836 Reduced 10.97%
266,480 $49.2 Million
Q2 2021

Aug 16, 2021

BUY
$170.47 - $211.93 $47.6 Million - $59.1 Million
279,084 Added 1379.42%
299,316 $53.7 Million
Q1 2021

May 17, 2021

BUY
$153.94 - $174.85 $203,816 - $231,501
1,324 Added 7.0%
20,232 $3.38 Million
Q4 2020

Feb 16, 2021

SELL
$101.87 - $151.79 $84,552 - $125,985
-830 Reduced 4.21%
18,908 $2.87 Million
Q3 2020

Nov 16, 2020

SELL
$99.9 - $121.13 $72,727 - $88,182
-728 Reduced 3.56%
19,738 $1.99 Million
Q2 2020

Aug 14, 2020

BUY
$92.74 - $125.82 $867,397 - $1.18 Million
9,353 Added 84.16%
20,466 $2.48 Million
Q1 2020

May 15, 2020

BUY
$79.39 - $115.35 $279,135 - $405,570
3,516 Added 46.28%
11,113 $1.05 Million
Q4 2019

Feb 14, 2020

SELL
$78.31 - $95.34 $4,933 - $6,006
-63 Reduced 0.82%
7,597 $669,000
Q2 2019

Aug 14, 2019

SELL
$76.06 - $120.81 $1.63 Million - $2.58 Million
-21,365 Reduced 73.61%
7,660 $598,000
Q1 2019

May 15, 2019

SELL
$107.15 - $126.84 $125,579 - $148,656
-1,172 Reduced 3.88%
29,025 $3.41 Million
Q4 2018

Feb 14, 2019

SELL
$101.4 - $128.73 $24,234 - $30,766
-239 Reduced 0.79%
30,197 $3.29 Million
Q3 2018

Nov 14, 2018

SELL
$113.81 - $129.46 $86,040 - $97,871
-756 Reduced 2.42%
30,436 $3.89 Million
Q2 2018

Aug 14, 2018

SELL
$101.14 - $118.31 $363,092 - $424,732
-3,590 Reduced 10.32%
31,192 $3.53 Million
Q1 2018

May 15, 2018

SELL
$107.21 - $151.94 $28,839 - $40,871
-269 Reduced 0.77%
34,782 $3.91 Million
Q4 2017

Feb 14, 2018

BUY
$118.58 - $151.28 $2.73 Million - $3.49 Million
23,045 Added 191.95%
35,051 $5.19 Million
Q3 2017

Nov 14, 2017

BUY
$114.6 - $136.81 $1.38 Million - $1.64 Million
12,006
12,006 $1.41 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.